197 related articles for article (PubMed ID: 10847550)
1. Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
Su LD; Duncan LM
J Cutan Pathol; 2000 May; 27(5):249-54. PubMed ID: 10847550
[TBL] [Abstract][Full Text] [Related]
2. CD30-positive atypical lymphoid cells in common non-neoplastic cutaneous infiltrates rich in neutrophils and eosinophils.
Cepeda LT; Pieretti M; Chapman SF; Horenstein MG
Am J Surg Pathol; 2003 Jul; 27(7):912-8. PubMed ID: 12826883
[TBL] [Abstract][Full Text] [Related]
3. Drug induced pseudolymphoma.
Magro CM; Daniels BH; Crowson AN
Semin Diagn Pathol; 2018 Jul; 35(4):247-259. PubMed ID: 29361381
[TBL] [Abstract][Full Text] [Related]
4. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
5. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
[TBL] [Abstract][Full Text] [Related]
6. Lymphomatoid papulosis type A: clinical, morphologic, and immunophenotypic study.
Sioutos N; Asvesti C; Sivridis E; Aygerinou G; Tsega A; Zakopoulou N; Zographakis I
Int J Dermatol; 1997 Jul; 36(7):514-7. PubMed ID: 9268749
[TBL] [Abstract][Full Text] [Related]
7. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.
Gill K; Ariyan C; Wang X; Brady MS; Pulitzer M
J Surg Oncol; 2014 Sep; 110(3):258-64. PubMed ID: 24891295
[TBL] [Abstract][Full Text] [Related]
8. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
Gallardo F; Barranco C; Toll A; Pujol RM
J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
[TBL] [Abstract][Full Text] [Related]
9. [Lymphomatoid papulosis and anaplastic giant-cell lymphoma].
Moreau-Cabarrot A; Bonafé JL; Gorguet B; Andrieu H; Massip P
Ann Dermatol Venereol; 1994; 121(10):727-30. PubMed ID: 7793765
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
Montes-Moreno S
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
[TBL] [Abstract][Full Text] [Related]
11. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S
Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
[TBL] [Abstract][Full Text] [Related]
12. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature.
McCarty MJ; Vukelja SJ; Sausville EA; Perry JJ; James WD; Jaffe ES; Weiss RB
Cancer; 1994 Dec; 74(11):3051-8. PubMed ID: 7954268
[TBL] [Abstract][Full Text] [Related]
13. Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin.
Cohen PL; Butmarc J; Kadin ME
Am J Clin Pathol; 1995 Jul; 104(1):50-3. PubMed ID: 7611181
[TBL] [Abstract][Full Text] [Related]
14. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
[TBL] [Abstract][Full Text] [Related]
15. Lymphomatoid papulosis: a clinical case.
Sass U; Shahabpour M; André J; Ledoux M
Dermatology; 1995; 190(4):327-9. PubMed ID: 7655118
[TBL] [Abstract][Full Text] [Related]
16. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous anaplastic large cell lymphoma.
Brown RA; Fernandez-Pol S; Kim J
J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
[TBL] [Abstract][Full Text] [Related]
18. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
Tomaszewski MM; Lupton GP; Krishnan J; May DL
J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous CD30 lymphoproliferative disorders and similar conditions: a clinical and pathologic prospective on a complex issue.
Guitart J; Querfeld C
Semin Diagn Pathol; 2009 Aug; 26(3):131-40. PubMed ID: 20043512
[TBL] [Abstract][Full Text] [Related]
20. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.
Werner B; Massone C; Kerl H; Cerroni L
J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]